Cargando…
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure
BACKGROUND: The Swiss label of oral fingolimod (0.5 mg once daily) requires a 6-hour first dose observation (FDO) including an ECG prior to and 6 hours after the first intake but in comparison to other countries such as Austria, Australia and Canada there are no restrictions regarding the clinical s...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405834/ https://www.ncbi.nlm.nih.gov/pubmed/25889400 http://dx.doi.org/10.1186/s40360-015-0006-0 |